An experimental anti-clotting medication, abelacimab, significantly reduced bleeding among people with atrial fibrillation (or AFib) who were at risk of stroke, according to results of the AZALEA-TIMI ...

A cross-University paper led by researchers at Queen Mary University of London, published in the Journal of Physiology shows ...

Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation. The study, published in Cell Reports Medicine, built on ongoing ...

In a simulated cohort of patients with subclinical device-detected atrial fibrillation (AF), broad use of direct oral ...

DEAR MAYO CLINIC: I had an episode of atrial fibrillation in 2004 and again in December 2005. Both were controlled in a few hours with medication. My doctor wants me to stay on medication. Is this ...

The diagnostic challenge is that many patients with OSA do not present with the classic symptoms clinicians often associate ...

We conducted an international, open-label, randomized, blinded-outcome-assessment trial involving 1284 patients who had undergone successful catheter ablation for atrial fibrillation at least 1 year ...

Depending on the type of irregular heartbeat (arrhythmia), medication can help slow or regulate a person’s heartbeat. Doctors will assess symptoms to decide the best medication. Medications for ...

Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition and a major cause of morbidity and mortality. Atrial fibrillation (AF) is the most common chronic arrhythmia in ...

Bleeding was reduced by more than 60% among people taking the anti-clotting agent abelacimab, demonstrating its safety for people at risk of stroke from atrial fibrillation. Abelacimab was compared ...